BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6424684)

  • 1. The effect of cyanide on the uptake of gold by red blood cells.
    Graham GG; Haavisto TM; Jones HM; Champion GD
    Biochem Pharmacol; 1984 Apr; 33(8):1257-62. PubMed ID: 6424684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. III. The formation of aurocyanide by myeloperoxidase.
    Graham GG; Kettle AJ
    Biochem Pharmacol; 1998 Aug; 56(3):307-12. PubMed ID: 9744567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--I. The effects of aurocyanide on the oxidative burst of polymorphonuclear leukocytes.
    Rudkowski R; Graham GG; Champion GD; Ziegler JB
    Biochem Pharmacol; 1990 Jun; 39(11):1687-95. PubMed ID: 2160817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--II. Evidence for the formation and biological activity of aurocyanide.
    Graham GG; Dale MM
    Biochem Pharmacol; 1990 Jun; 39(11):1697-702. PubMed ID: 2160818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of smoking on the distribution of gold in blood.
    Graham GG; Haavisto TM; McNaught PJ; Browne CD; Champion GD
    J Rheumatol; 1982; 9(4):527-31. PubMed ID: 6813468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H, 13C NMR, and electronic absorption spectroscopic studies of the interaction of cyanide with aurothiomalate.
    Graham GG; Bales JR; Grootveld MC; Sadler PJ
    J Inorg Biochem; 1985 Nov; 25(3):163-73. PubMed ID: 3934340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular metabolism and effects of gold complexes.
    Graham GG; Champion GD; Ziegler JB
    Met Based Drugs; 1994; 1(5-6):395-404. PubMed ID: 18476258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intracellular gold content of circulating blood cells using various gold compounds].
    Herrlinger JD; Beress R; Hecker U
    Wien Klin Wochenschr Suppl; 1984; 156():13-6. PubMed ID: 6442048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
    Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
    Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.
    Danpure CJ; Fyfe DA; Gumpel JM
    Ann Rheum Dis; 1979 Aug; 38(4):364-70. PubMed ID: 115389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of gold in serum erythrocytes and white blood cells after in vitro incubation and during chrysotherapy with different gold compounds.
    Herrlinger JD; Alsen C; Beress R; Hecker U; Weikert W
    J Rheumatol Suppl; 1982; 8():81-9. PubMed ID: 6813496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice.
    Jellum E; Munthe E; Guldal G; Aaseth J
    Ann Rheum Dis; 1980 Apr; 39(2):155-8. PubMed ID: 6770766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 1H nmr study of the interaction of aurothiomalate ("Myocrisin") with human red blood cells in vitro.
    Otiko G; Razi MT; Sadler PJ; Isab AA; Rabenstein DL
    J Inorg Biochem; 1983 Nov; 19(3):227-35. PubMed ID: 6417270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold concentrations in blood fractions of patients with rheumatoid arthritis treated with Myocrisin.
    Egila J; Littlejohn D; Smith WE; Sturrock RD
    J Pharm Biomed Anal; 1992 Sep; 10(9):639-44. PubMed ID: 1286129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dicyanogold (I) is a common human metabolite of different gold drugs.
    Elder RC; Zhao Z; Zhang Y; Dorsey JG; Hess EV; Tepperman K
    J Rheumatol; 1993 Feb; 20(2):268-72. PubMed ID: 8474063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of cyanide and thiocyanate in blood plasma and red cells by high-performance liquid chromatography with fluorometric detection.
    Toida T; Togawa T; Tanabe S; Imanari T
    J Chromatogr; 1984 Jun; 308():133-41. PubMed ID: 6746810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum gold. I. Estimation by atomic absorption spectroscopy.
    Dietz AA; Rubinstein HM
    Ann Rheum Dis; 1973 Mar; 32(2):124-7. PubMed ID: 4632660
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholestatic hepatitis caused by acute gold potassium cyanide poisoning.
    Wu ML; Tsai WJ; Ger J; Deng JF; Tsay SH; Yang MH
    J Toxicol Clin Toxicol; 2001; 39(7):739-43. PubMed ID: 11778673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell cyanide.
    Vesey CJ; Wilson J
    J Pharm Pharmacol; 1978 Jan; 30(1):20-6. PubMed ID: 22720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.